CCL18 and interstitial lung disease: In BALF, behind the autoantibodies (anti-Scl-70, anti-centromer antibodies, anti-Ro52), CCL18, macrophage 2-derived protein, has been also described to be sensitive for monitoring the progression of SSc-ILD.